Mivebresib(ABBV-075) Pipets

Mivebresib(ABBV-075) PipetsMivebresib(ABBV 075) is a novel BET family bromodomain inhibitor. It binds bromodomains of BRD2 4 T with similar affinities (Ki of 1 2. 2 nM) and highly selective for 18 bromodomain proteins tested (Kd > 1 ? M; more than 600 fold selectivity vs. BRD4), but exhibits roughly 10 fold weaker potency towards BRD3 (Ki of 12. 2 nM) and has moderate activity towards CREBBP (Kd = 87 ? M; 54 fold selectivity vs. BRD4).

possesses superior drug properties: delivery across the blood-brain barrier

modest activity against raltegravir-resistant signature mutants Y143R

170-fold more selective for DNA-PK activity compared to PI3K activity

NSC 207895 suppresses MDMX with IC50 of 2

It also has high affinity for serotonin 5-HT7 receptors (Ki = 0

third-generation cephalosporin with antibacterial activity

25 nM and 16 nM for Pim1

Corning These flat PYREX® dishes have approximately a 1770mL capacity with rims that are reinforced and fire polished to reduce chipping

Corning These 10mL PYREX® graduated cylinders are calibrated "to contain" (TC)

selective prostacyclin IP receptor agonist with Ki value of 260 nM for human IP

It binds to PD-1 with high affinity and inhibits the biological activity of PD-1

and enzymatic functions of the intestinal tract